Prognostic Nutritional Index and Neutrophil-to-Lymphocyte Ratio Are Respectively Associated with Prognosis of Gastric Cancer with Liver Metatasis Undergoing and without Hepatectomy

Table 3

Comparison of characteristics between GCLM undergoing and without hepatectomy.

Patients	GCLM undergoing hepatectomy,	GCLM without hepatectomy,	p
Parameter	(%)/mean ± SD
Gender			0.538
Male	43 (79.6)	256 (80.0)
Female	11 (20.4)	64 (20.0)
Age	57.0 ± 10.5	56.8 ± 10.9	0.206
Albumin (g/L)	39.3 ± 5.10	39.7 ± 5.70	0.674
Lymphocyte (/10^9L)	2.50 ± 1.56	2.25 ± 1.34	0.206
Neutrophil (/10^9L)	4.63 ± 2.75	4.86 ± 2.48	0.540
T stage			0.017^∗
T4b	25 (46.3)	201 (62.8)
Not T4b	29 (53.7)	119 (37.2)
N stage			0.499
N0 or N1	18 (33.3)	104 (32.5)
N2 or N3	36 (66.7)	216 (67.5)
Number of liver metastases			0.001^∗
Single	38 (70.4)	120 (37.5)
Multiple	16 (29.6)	200 (62.5)
Gastrectomy			0.001^∗
Yes	54 (100.0)	105 (32.8)
No	0 (0.0)	215 (67.2)
Chemotherapy			0.451
Yes	24 (44.4)	136 (42.5)
No or Uncertain	30 (55.6)	184 (57.5)
PNI	49.0 ± 6.70	49.0 ± 7.17	0.907
NLR	3.35 ± 2.86	3.32 ± 2.11	0.936

^∗